Development of a CRISPR/Cpf1 system for targeted gene disruption in Aspergillus aculeatus TBRC 277

BACKGROUND: CRISPR-Cas genome editing technologies have revolutionized biotechnological research particularly in functional genomics and synthetic biology. As an alternative to the most studied and well-developed CRISPR/Cas9, a new class 2 (type V) CRISPR-Cas system called Cpf1 has emerged as anothe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Biotechnol
Auteurs principaux: Abdulrachman, Dede, Eurwilaichitr, Lily, Champreda, Verawat, Chantasingh, Duriya, Pootanakit, Kusol
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879532/
https://ncbi.nlm.nih.gov/pubmed/33573639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12896-021-00669-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires